Exposomic Contributions to ADRD Pathology and Resilience
This is a forecasted opportunity — a pre-announcement that isn’t open for applications yet. Dates and details may change before it posts.
This is a forecasted (not yet open) NIH funding opportunity focused on how environmental exposures (the exposome) contribute to Alzheimer's disease and related dementias pathology and resilience. I…
- Deadline
- Not specified
- Posted
- Mar 11, 2026
- Award amount
- Amount not specified
In plain English
This is a forecasted (not yet open) NIH funding opportunity focused on how environmental exposures (the exposome) contribute to Alzheimer's disease and related dementias pathology and resilience. It is research-oriented and would typically suit universities, research institutions, and scientists with relevant expertise. Eligibility, funding amounts, and deadlines have not yet been published, so applicants should monitor for the full announcement.
AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.
Let AI draft your application
Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.
Application Kit — $49 one-time
Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.
Get the Application Kit →Related grants
Other open grants from National Institutes of Health — soonest deadline first.
Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required)
National Institutes of Health · Amount varies · Closed
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health · Amount varies · Due in 3 days
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health · Up to $1M · Due in 3 days
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
National Institutes of Health · Amount varies · Due in 5 days
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health · Amount varies · Due in 8 days
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
National Institutes of Health · Up to $250K · Due in 8 days
Also listed under National Institutes of Health.
Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.